E6011

· EA Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for E6011, covering 2014-02-14 to 2025-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of E6011 in Participants With Active Crohn's Disease [Phase 2]